CTT PHARMACEUTICAL HOLDINGS, INC. purchased $204 of CTTH
CTT PHARMACEUTICAL HOLDINGS, INC. (CEO) purchased 3,700 shares of CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH) at $0.06 on 2026-10-06.
How this was made
The 30-second read
Why it matters
The CEO's purchase is modest and unlikely to move the stock significantly, but it adds a data point for future monitoring.
Market read
Limited relevance; the insider purchase is small and does not constitute a material catalyst.
What to watch
Potential upcoming corporate actions or financing needs that prompted the buy are not disclosed.
Background
SEC Form 4 filings disclose insider transactions; investors monitor them for signals of insider confidence.
Ticker impact
CEO purchased 3,700 shares for $203.50, increasing holdings to over 9.4 million shares.
minimal upward pressure as the market prices the insider confidence
The transaction size is tiny relative to the company's market cap; any price effect will be limited.
Market effects
none
none
none
Counterpoint
The purchase could be a routine portfolio rebalancing rather than a strong bullish signal.
Key entities
- companyCTT Pharmaceutical Holdings, Inc.
Biopharmaceutical company filing the insider transaction.